MichaelAHannaMD

Cardiology • Gates Mills, OH

Adult Congenital Heart Disease

Physician

Join to view full profile

Dr. Hanna is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hanna's full profile

Already have an account?

Office
retired
Gates Mills, OH 44040
Phone+1 440-785-1081
Is this information wrong?

Education & Training

Huron HospitalResidency, Internal Medicine, 1970 - 1971
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1968 - 1970
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1966 - 1968
Huron HospitalResidency, Internal Medicine, 1965 - 1966
Huron HospitalInternship, Transitional Year, 1964 - 1965
Damascus University Faculty of MedicineClass of 1964

Certifications & Licensure

OH State Medical License 1971 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology
Top MD Consumers Checkbook

Publications & Presentations

PubMed

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin.
Guimarães, P. O.,Lopes, R. D.,Alexander, J. H.,Thomas, L.,Hellkamp, A. S.,Hijazi, Z.,Hylek, E. M.,Gersh, B. J.,Garcia, D. A.,Verheugt, FWA.,Hanna, M.,Flaker, G.,Vinere...> ;J. Thromb. Thrombolysis. 2019 Apr 12
Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Prior Bioprosthetic Valve Replacement or Valve Repair: Insights from the ARIST...
Guimarães, P. O.,Pokorney, S. D.,Lopes, R. D.,Wojdyla, D. M.,Gersh, B. J.,Giczewska, A.,Carnicelli, A.,Lewis, B. S.,Hanna, M.,Wallentin, L.,Vinereanu, D.,Alexander, J....> ;Clin Cardiol. 2019 Mar 25
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.
Washam, J. B.,Hohnloser, S. H.,Lopes, R. D.,Wojdyla, D. M.,Vinereanu, D.,Alexander, J. H.,Gersh, B. J.,Hanna, M.,Horowitz, J.,Hylek, E. M.,Xavier, D.,Verheugt, FWA.,Wa...> ;J. Thromb. Thrombolysis. 2019 Feb 23
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
Horowitz, J. D.,De Caterina, R.,Heresztyn, T.,Alexander, J. H.,Andersson, U.,Lopes, R. D.,Steg, P. G.,Hylek, E. M.,Mohan, P.,Hanna, M.,Jansky, P.,Granger, C. B.,Wallen...> ;J. Am. Coll. Cardiol.. 2018 Aug 11
9 citations
Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
Dragos Vinereanu, Alice Wang, Hillary Mulder, Renato D. Lopes, Petr Jansky, Basil S. Lewis, Bernard J. Gersh, Alvaro Avezum, Michael G. Hanna, Claes Held, Lars Wallent...> ;Heart. 2018 Jan 19
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin.
Vinereanu, D.,Lopes, R. D.,Mulder, H.,Gersh, B. J.,Hanna, M.,de Barros E Silva, PGM.,Atar, D.,Wallentin, L.,Granger, C. B.,Alexander, J. H.> ;Stroke. 2017 Nov 02
Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
Guimarães PO, Wojdyla DM, Alexander JH, Thomas L, Alings M, Flaker GC, Al-Khatib SM, Hanna M, Horowitz JD, Wallentin L, Granger CB, Lopes RD> ;Int. J. Cardiol.. 2016-11-07
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
Bahit MC, Lopes RD, Wojdyla DM, Held C, Hanna M, Vinereanu D, Hylek EM, Verheugt F, Goto S, Alexander JH, Wallentin L, Granger CB> ;Heart. 2016-10-24
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)...
Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes RD, Wallentin L> ;Eur. Heart J.. 2016-10-07
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a R...
Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L> ;JAMA Cardiol. 2016-09-01
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Random...
Hijazi Z, Hohnloser SH, Andersson U, Alexander JH, Hanna M, Keltai M, Parkhomenko A, López-Sendón JL, Lopes RD, Siegbahn A, Granger CB, Wallentin L> ;JAMA Cardiol. 2016-07-01
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
Hijazi Z, Lindbäck J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RAH, White HD, Granger CB, Wallentin L> ;Eur. Heart J.. 2016-05-21
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Ev...
De Caterina R, Andersson U, Alexander JH, Al-Khatib SM, Bahit MC, Goto S, Hanna M, Held C, Hohnloser S, Hylek EM, Lanas F, Lopes RD, López-Sendón J, Renda G, Horowitz ...> ;Am. Heart J.. 2016-05-01
Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
Hijazi Z, Aulin J, Andersson U, Alexander JH, Gersh B, Granger CB, Hanna M, Horowitz J, Hylek EM, Lopes RD, Siegbahn A, Wallentin L> ;Heart. 2016-04-01
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controll...
Vinereanu, D.,Stevens, S. R.,Alexander, J. H.,Al-Khatib, S. M.,Avezum, A.,Bahit, M. C.,Granger, C. B.,Lopes, R. D.,Halvorsen, S.,Hanna, M.,Husted, S.,Hylek, E. M.,Mărg...> ;Eur. Heart J.. 2015 Sep 16
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thro...
Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M, Pais P, Erol C, Diaz R, Bahit MC, Bartunek J, De Caterina R, Goto S, Ruzyllo W, Zhu J, Granger CB, Alexande...> ;Circulation. 2015-08-25
Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
Held C, Hylek EM, Alexander JH, Hanna M, Lopes RD, Wojdyla DM, Thomas L, Al-Khalidi H, Alings M, Xavier D, Ansell J, Goto S, Ruzyllo W, Rosenqvist M, Verheugt FWA, Zhu...> ;Eur. Heart J.. 2015-05-21
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial.
Ezekowitz JA, Lewis BS, Lopes RD, Wojdyla DM, McMurray JJV, Hanna M, Atar D, Cecilia Bahit M, Keltai M, Lopez-Sendon JL, Pais P, Ruzyllo W, Wallentin L, Granger CB, Al...> ;Eur Heart J Cardiovasc Pharmacother. 2015-04-01
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy.
Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola V, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJV, W...> ;Clin. Chem.. 2015-02-01
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atr...
Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, Thomas L, Wang J, Bahit MC, Verheugt F, Lawrence J, Xavier D, Wallentin L> ;Am. Heart J.. 2015-01-01
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban f...
Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, Horowitz JD, Hylek EM, Lopes RD, Asberg S, Granger CB, Siegbahn A> ;Circulation. 2014-11-18
Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
Flaker, G.,Lopes, R. D.,Hylek, E.,Wojdyla, D. M.,Thomas, L.,Al-Khatib, S. M.,Sullivan, R. M.,Hohnloser, S. H.,Garcia, D.,Hanna, M.,Amerena, J.,Harjola, V. P.,Dorian, P...> ;J. Am. Coll. Cardiol.. 2014 Oct 11
Management and clinical outcomes in patients treated with apixaban versus warfarin undergoing procedures.
Garcia, D.,Alexander, J. H.,Wallentin, L.,Wojdyla, D. M.,Thomas, L.,Hanna, M.,Al-Khatib, S. M.,Dorian, P.,Ansell, J.,Commerford, P.,Flaker, G.,Lanas, F.,Vinereanu, D.,...> ;Blood. 2014 Oct 17
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Red...
Goto S, Zhu J, Liu L, Oh B, Wojdyla DM, Aylward P, Bahit MC, Gersh BJ, Hanna M, Horowitz J, Lopes RD, Wallentin L, Xavier D, Alexander JH> ;Am. Heart J.. 2014-09-01
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial.
Christersson C, Wallentin L, Andersson U, Alexander JH, Ansell J, De Caterina R, Gersh BJ, Granger CB, Hanna M, Horowitz JD, Huber K, Husted S, Hylek EM, Lopes RD, Sie...> ;J. Thromb. Haemost.. 2014-09-01
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Fellow

Hospital Affiliations

Cleveland Clinic Hillcrest HospitalCleveland, Ohio
Cleveland Clinic South Pointe HospitalBeachwood, Ohio
Corewell Health William Beaumont University HospitalRoyal Oak, Michigan